Frovocimab, CAS 1643672-70-1

Product Description: Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Krista M Schroeder, et al. Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibody. J Lipid Res. 2015 Nov;56(11):2124-32.

CAS Number: 1643672-70-1

Molecular Weight: N/A

Research Area: Metabolic Disease

Solubility: 10 mM in DMSO

Target: PCSK9

• SKU: MEXHY-P99626-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99626-5
• Package Unit: 5mg
• Quantity Unit: STK
• Conjugate: Unconjugated